EUGENIA GIULIANI

PhD Graduate

PhD program:: XXXIII



Thesis title: NOTCH3 INHIBITION IN THE DEVELOPMENT OF NEW COMBINED THERAPEUTIC STRATEGIES

Since cancer is the second cause of death after cardiovascular diseases around the world, adequate and effective treatments are required, especially because every cancer type is different. To date, the common treatment modalities used are surgery, radiotherapy or chemotherapy but they are often unsuccessful. Therefore, the study of the molecular pathways which are mainly involved in tumor initiation and progression may contribute to the development of more effective targeted therapy. Among them, the Notch signaling pathway, which comprises four evolutionary conserved single-pass transmembrane proteins, is involved in the regulation of the balance between cell proliferation and apoptosis during embryogenesis and in adult tissues. Given its pleiotropic effects, Notch signaling aberration, deriving from mutations or genetic alterations, has been confirmed in the context of various tumor types, where often correlates with the patients prognosis. Despite some Notch inhibitors are clinically used in different cancer contexts, they did not give significant responses and cures, also due to the known adverse effects deriving from monotherapy. However, it has been demonstrated that they are very useful in combination with current available treatment modalities, including chemotherapy, radiation and/or other pathways inhibitors, particularly for the additive or synergic effects resulting from the combination therapy. Additionally, considering Notch pathway implication in the acquisition of tumor resistance, Notch inhibitors can re-sensitised the drug-resistant cancers to common therapies. Thus, the “Notch- combination therapy” may be considered a promising therapeutic strategy. The main objective of this work is to dissect the advantages of the combination therapy based on the inhibition of the Notch3 pathway, in order to display how its modulation could be productive and beneficial to cancer-bearing patients. In the article exposed at Chapter 1, we observed how Notch3 inhibition in T-ALLs can be used to amplify the anti-tumour effect of the associated treatment and to decrease the potentially toxic effects deriving from the higher doses associated with both monotherapies. In both Chapter 2 and Chapter 3 we proposed the Notch3 inhibition as a potential approach for overcoming drug resistance. Thus, these projects highlight the Notch pathway, and specifically the Notch3 pathway, as a crucial drug target in the development of new combination therapeutic approaches.

Research products

11573/1502473 - 2021 - Anal and oral human papillomavirus infection in men who have sex with men: implications for risk-targeted vaccination
Dona, M. G.; Rollo, F.; Latini, A.; Benevolo, M.; Pichi, B.; Pellini, R.; Giuliani, E.; Giglio, A.; Cristaudo, A.; Giuliani, M. - 01a Articolo in rivista
paper: FUTURE MICROBIOLOGY (London : Future Medicine, 2006-.) pp. 1713-1722 - issn: 1746-0913 - wos: WOS:000605950600002 (5) - scopus: 2-s2.0-85099170684 (5)

11573/1446421 - 2020 - Notch3 contributes to T-cell leukemia growth via regulation of the unfolded protein response
Giuli, Maria Valeria; Diluvio, Giulia; Giuliani, Eugenia; Franciosa, Giulia; Di Magno, Laura; Pignataro, Maria Gemma; Tottone, Luca; Nicoletti, Carmine; Besharat, Zein Mersini; Peruzzi, Giovanna; Pelullo, Maria; Palermo, Rocco; Canettieri, Gianluca; Talora, Claudio; D'amati, Giulia; Bellavia, Diana; Screpanti, Isabella; Checquolo, Saula - 01a Articolo in rivista
paper: ONCOGENESIS (London Nature Publishing Group) pp. 1-16 - issn: 2157-9024 - wos: WOS:000579242100001 (15) - scopus: 2-s2.0-85092794807 (14)

11573/1303782 - 2019 - Notch signaling activation as a hallmark for triple-negative breast cancer subtype
Giuli, M. V.; Giuliani, E.; Screpanti, I.; Bellavia, D.; Checquolo, S. - 01g Articolo di rassegna (Review)
paper: JOURNAL OF ONCOLOGY (Cairo: Hindawi Publishing Corporation) pp. - - issn: 1687-8450 - wos: WOS:000476770500001 (112) - scopus: 2-s2.0-85069758376 (115)

11573/1344899 - 2019 - Molecular basis of Notch3-Pin1 functional crosstalk in aggressive female tumors: therapeutic targeting implications in ovarian cancer treatment
Giuli, Mv; Giuliani, E; Mancusi, A; Franciosa, G; Olsen, Jv; Screpanti, I; Checquolo, S - 04d Abstract in atti di convegno
conference: SIPMeT Young Meeting (Firenze, Italy)
book: PATHOBIOLOGY: FROM MOLECULAR DISEASE TO CLINICAL APPLICATION - ()

11573/1344900 - 2019 - Notch3-Pin1 crosstalk in ovarian cancer: from molecular mechanism dissection to therapeutic application
Giuli, Mv; Giuliani, E; Mancusi, A; Franciosa, G; Olsen, Jv; Screpanti, I; Checquolo, S - 04d Abstract in atti di convegno
conference: The XI Notch meeting (Athens, Greece)
book: The XI Notch meeting - ()

11573/1344902 - 2019 - Getting insights into Pin1-Notch3 functional crosstalk in ovarian cancer
Giuli, Mv; Giuliani, E; Mancusi, A; Franciosa, G; Olsen, Jv; Screpanti, I; Checquolo, S - 04d Abstract in atti di convegno
conference: 4Th ANNUAL MEETING OF ALLIANCE AGAINST CANCER (ACC) (Roma, Italy)
book: NEW TECHNOLOGIES TO FIGHT CANCER - ()

11573/1347680 - 2019 - Notch3 contributes to T-cell leukemia growth via regulation of the unfolding protein response
Giuliani, Eugenia; Giuli, Maria Valeria; Diluvio, Giulia; Pelullo, Maria; Palermo, Rocco; Talora, Claudio; Bellavia, Diana; Screpanti, Isabella; Checquolo, Saula - 04d Abstract in atti di convegno
conference: The Biennial Congress of the Italian Association of cell biology and differentiation (Bologna, Italy)
book: The Biennial Congress of the Italian Association of cell biology and differentiation - ()

11573/1111436 - 2018 - NOTCH3 inactivation increases triple negative breast cancer sensitivity to gefitinib by promoting EGFR tyrosine dephosphorylation and its intracellular arrest
Diluvio, Giulia; Del Gaudio, Francesca; Giuli, Maria Valeria; Franciosa, Giulia; Giuliani, Eugenia; Palermo, Rocco; Besharat, Zein Mersini; Pignataro, Maria Gemma; Vacca, Alessandra; D'amati, Giulia; Maroder, Marella; Talora, Claudio; Capalbo, Carlo; Bellavia, Diana; Checquolo, Saula - 01a Articolo in rivista
paper: ONCOGENESIS (London Nature Publishing Group) pp. - - issn: 2157-9024 - wos: WOS:000433997800002 (39) - scopus: 2-s2.0-85047628678 (41)

11573/1114780 - 2018 - Targeting the ER/UPR signalling in Notch3-overexpressing T-cell acute lymphoblastic leukemia.
Giuli, Mv; Diluvio, G; Giuliani, E; Bellavia, D; Palermo, R; Screpanti, I; Checquolo, S - 04d Abstract in atti di convegno
conference: ABCD - Ph.D. meeting (Salerno)
book: Atti del ABCD - Ph.D. meeting - ()

11573/1344887 - 2018 - Potential targeted therapy for T-cell acute lymphoblastic leukemia: perturbing ER/UPR signaling via Notch3 down-regulation
Giuli, Mv; Diluvio, G; Giuliani, E; Bellavia, D; Palermo, R; Screpanti, I; Checquolo, S - 04d Abstract in atti di convegno
conference: 31st Annual conference of Italian Association of Cell Cultures (AICC) (Bologna, Italy)
book: Cell communication and signaling: how to turn bad language into positive one - ()

11573/1174598 - 2018 - NOTCH3 inactivation increases Triple Negative Breast Cancer sensitivity to gefitinib by promoting EGFR tyrosine dephosphorylation and its intracellular arrest.
Giuliani, Eugenia; Giuli, Maria Valeria; Diluvio, Giulia; Del Gaudio, Francesca; Franciosa, Giulia; Bellavia, Diana; Screpanti, Isabella; Checquolo, Saula - 04d Abstract in atti di convegno
conference: ABCD - Ph.D. meeting (Salerno)
book: Atti del ABCD - PPh.D. meeting - ()

11573/1348519 - 2018 - Vaccine-preventable anal infections by human papillomavirus among HIV-infected men who have sex with men
Giuliani, Massimo; Latini, Alessandra; Colafigli, Manuela; Benevolo, Maria; Rollo, Francesca; Zaccarelli, Mauro; Giuliani, Eugenia; Moretto, Domenico; Giglio, Amalia; Rezza, Giovanni; Cristaudo, Antonio; Donà, Maria G. - 01a Articolo in rivista
paper: FUTURE MICROBIOLOGY (London : Future Medicine, 2006-.) pp. 1463-1472 - issn: 1746-0913 - wos: WOS:000452419200005 (3) - scopus: 2-s2.0-85055144142 (3)

11573/1022327 - 2017 - Cytotoxic activity of Juglone against Notch3-overexpressing T-cell acute lymphoblastic leukemia: targeting the ER/UPR signaling
Giuli, Mv; Diluvio, G.; Giuliani, Eugenia; Bellavia, D.; Palermo, R.; Screpanti, I.; Checquolo, S. - 04d Abstract in atti di convegno
book: Notch meeting X - ()

11573/1114777 - 2017 - Role of Notch3 in sustaining UPR signaling in Notch3-overexpressing T-cell acute lymphoblastic leukemia.
Giuli, Mv; Diluvio, G; Giuliani, E; Bellavia, D; Palermo, R; Screpanti, I; Checquolo, S - 04d Abstract in atti di convegno
conference: SIPMeT "Young Scientist Meeting" (Milano)
book: Atti del SIPMeT "Young Scientist Meeting" - ()

© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma